DCGI

Zydus Applies to the DCGI for EUA to Launch ZyCoV-D

AHMEDABAD:Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to the office of Drug Controller…

3 years ago

Glenmark Launch Remogliflozin + Vildagliptin Fixed Dose Combination for Type 2 Diabetes

KOCHI:Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination (FDC) of its novel, patent…

3 years ago

BDR Receives DCGI Approval for Favipiravir to Treat COVID-19

MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients in India. BDR Pharma has…

4 years ago

Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir

KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet…

4 years ago

This website uses cookies.